Remove 2010 Remove Clinical Trials Remove Events
article thumbnail

Cannabis Use In Active Athletes: Behaviors Related to Subjective Effects

Puff Puff Post

raced as a professional triathlete from 1998-2010. She is a seven-time Olympic trials qualifier in three sports: marathon (three), triathlon (three), and swimming (one). When she is not training for running events, Dr. Zeiger works as a cannabis epidemiologist. Study co-author Joanna Zeiger, MS, Ph.D.

article thumbnail

Cannabis Use In Active Athletes: Behaviors Related to Subjective Effects

Puff Puff Post

raced as a professional triathlete from 1998-2010. She is a seven-time Olympic trials qualifier in three sports: marathon (three), triathlon (three), and swimming (one). When she is not training for running events, Dr. Zeiger works as a cannabis epidemiologist. Study co-author Joanna Zeiger, MS, Ph.D.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers

Cannabis Law Report

We look forward to providing continued updates on our intellectual property, research, clinical, regulatory and manufacturing activities for PD-001; our novel oral formulation of cepharanthine, with the aim of working towards a first-in-human, proof-of-concept clinical trial under an FDA IND approval.” Epub 2010 Dec 17.

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

article thumbnail

Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director

Cannabis Law Report

NYSE: AMAM), a position he previously held from 2010 through 2015. I am so very proud of all Anebulo has achieved over the past 18 months, including building out a highly effective team, securing new intellectual property protection, preparing and starting a proof-of-concept clinical trial, advancing regulatory discussions with the U.S.

article thumbnail

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Cannabis Law Report

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. She was Founder and Executive Producer of the award-winning future-shaping events series, Creative Innovation Global. Tania de Jong AM.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, from 2010, a dramatic increase is observable in articles about medicinal cannabis in the publications under analysis. It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis. 23), followed by adverse events ( n ?=?15) Google Scholar.